{"id":19400,"date":"2025-09-19T21:50:05","date_gmt":"2025-09-19T18:50:05","guid":{"rendered":"https:\/\/testsunucusu.com\/acibadem\/doctor\/orcun-can\/"},"modified":"2025-12-10T21:36:17","modified_gmt":"2025-12-10T18:36:17","slug":"orcun-can","status":"publish","type":"idel_doctor","link":"https:\/\/acibademinternational.com\/doctor\/orcun-can\/","title":{"rendered":"Or\u00e7un Can"},"content":{"rendered":"<p><!-- Education & Experience --><\/p>\n<div class=\"info-education\">\n<p>M.D. <strong>Or\u00e7un Can<\/strong> is a medical oncologist trained at Okmeydan\u0131 Training and Research Hospital, where he completed his specialty training in 2018. He has been practicing with Ac\u0131badem Health Group since 2023, providing evidence-based cancer care and participating in multidisciplinary treatment planning. He is an active member of leading professional societies, including the Turkish Society of Medical Oncology (TTOD), the European Society for Medical Oncology (ESMO), and the American Society of Clinical Oncology (ASCO). These memberships reflect his commitment to staying current with international advances in oncology and to delivering high-quality, patient-centered care.<\/p>\n<div style=\"height: 20px;\"><\/div>\n<p><strong>Education<\/strong><\/p>\n<ul>\n<li><span class=\"doctorDate\">2018<\/span> <span class=\"doctorDescription\">Okmeydan\u0131 Training and Research Hospital Medical Oncology<\/span><\/li>\n<li><span class=\"doctorDate\">2014<\/span> <span class=\"doctorDescription\">Medeniyet University G\u00f6ztepe Training and Research Hospital Internal Medicine<\/span><\/li>\n<li><span class=\"doctorDate\">2009<\/span> <span class=\"doctorDescription\">Cukurova University Faculty of Medicine<\/span><\/li>\n<\/ul>\n<p><strong>Experience<\/strong><\/p>\n<ul>\n<li><span class=\"doctorDate\">2023<\/span> <span class=\"doctorDescription\">Acibadem Health Group<\/span><\/li>\n<li><span class=\"doctorDate\">2018 \u2013 2021<\/span> <span class=\"doctorDescription\">Istanbul Prof. Dr. Cemil Tascioglu City Hospital \/ Medical Oncology \/ Specialist Doctor<\/span><\/li>\n<li><span class=\"doctorDate\">2018<\/span> <span class=\"doctorDescription\">Nev\u015fehir State Hospital \/ Medical Oncology \/ Specialist Doctor<\/span><\/li>\n<li><span class=\"doctorDate\">2015 \u2013 2018<\/span> <span class=\"doctorDescription\">Istanbul Okmeydan\u0131 Training and Research Hospital \/ Assistant<\/span><\/li>\n<li><span class=\"doctorDate\">2014 \u2013 2015<\/span> <span class=\"doctorDescription\">Kirklareli Pinarhisar State Hospital \/ Internal Medicine \/ Specialist Doctor<\/span><\/li>\n<li><span class=\"doctorDate\">2009<\/span> <span class=\"doctorDescription\">Mersin Tarsus \u00c7i\u00e7ekli Health Center \/ General Practitioner<\/span><\/li>\n<\/ul>\n<p><strong>Memberships<\/strong><\/p>\n<ul>\n<li><span class=\"doctorDescription\">TTOD (Turkish Society of Medical Oncology)<\/span><\/li>\n<li><span class=\"doctorDescription\">ESMO (European Society for Medical Oncology)<\/span><\/li>\n<li><span class=\"doctorDescription\">ASCO (American Society of Clinical Oncology)<\/span><\/li>\n<\/ul>\n<p><strong>Publications<\/strong><\/p>\n<ul>\n<li><strong>Clinical Features and Prognostic Factors of Metastatic Non-Clear Cell Renal Cell Carcinoma: A Multicenter Study from the Turkish Oncology Group Kidney Cancer Consortium<\/strong><br>\nUrologia Internationalis, 107(6), 595-601., Doi: 10.1159\/000528994 (Publication No: 8436265) (2023) EROL C\u0130HAN, YEKEDUZ EMRE, TURAL DEN\u0130Z, KARAKAYA SERDAR, \u015eENT\u00dcRK \u00d6ZTA\u015e N\u0130HAN, U\u00c7AR G\u00d6KHAN, KILI\u00c7KAP SADETT\u0130N, ERT\u00dcRK \u0130SMA\u0130L, SEVER \u00d6ZLEM NURAY, ARSL<\/li>\n<li><strong>External Validation of a Novel Risk Model in Patients With Favorable Risk Renal Cell Carcinoma Defined by International Metastatic Renal Cell Carcinoma Database Consortium (IMDC): Results From the Turkish Oncology Group Kidney Cancer Consortium (TKCC) Database<\/strong><br>\nClinical Genitourinary Cancer, 21(1), 175-182., Doi: 10.1016\/j.clgc.2022.07.006 (Publication No: 8124532) (2023) YEKED\u00dcZ EMRE, KARAKAYA SERDAR, ERT\u00dcRK \u0130SMA\u0130L, TURAL DEN\u0130Z, U\u00c7AR G\u00d6KHAN, \u015eENT\u00dcRK \u00d6ZTA\u015e N\u0130HAN, ARIKAN RUK\u0130YE, HIZAL MUTLU, K\u00dc\u00c7\u00dcKARDA AHMET, SEVER \u00d6ZL<\/li>\n<li><strong>How reliable is the high-volume definition in prostate cancer patients: the potential game-changing role of PSMA<\/strong><br>\nNuclear Medicine Communications, 44(9), 816-824., Doi: 10.1097\/MNM.0000000000001722 (Publication No: 8436253 (2023)) G\u00dcVEN OSMAN, KARYA\u011eAR SAVA\u015e, ARICI SERDAR, \u00d6Z\u00dcLKER TAMER, CAN OR\u00c7UN<\/li>\n<li><strong>Serum fetuin-A and RANKL levels in patients with early stage breast cancer<\/strong><br>\nJournal of Medical Biochemistry, 42(2), 249-257., Doi: 10.5937\/jomb0-37386 (Publication No: 8436129) (2023) AV\u015eAR USUL \u00c7\u0130\u011eDEM, ARAL HALE, CAN OR\u00c7UN, CAN TRABLUS D\u0130DEM, KARA\u00c7ET\u0130N D\u0130DEM, NAZLI MEHMET AL\u0130, G\u00dcRSU RIZA UMAR, KARABULUT SENEM<\/li>\n<li><strong>Efficacy of Imatinib on Advanced and Refractory Desmoid Tumors: A Retrospective Study.<\/strong><br>\nJournal of Oncological Sciences (JOS), 8(2), 63-68., Doi: 10.37047\/jos.2021-87391 (Control No: 8214846) (2022) ATCI MUHAMMED MUSTAFA, CAN OR\u00c7UN, SE\u00c7MELER \u015eABAN, SAK\u0130N ABDULLAH, AY ERSOY SEVAL, C\u0130HAN \u015eENER, SELV\u0130 O\u011eUZHAN, GEREDEL\u0130 \u00c7A\u011eLAYAN<\/li>\n<li><strong>The relationship between pan-immune-inflammation value and survival outcomes in patients with metastatic renal cell carcinoma treated with nivolumab i in the second line and beyond: a Turkish oncology group kidney cancer consortium (TKCC) study<\/strong><br>\nJournal of Cancer Research and Clinical Oncology, 148(12), 3537-3546., Doi: 10.1007\/s00432-022-04055-5 (Publication No: 7696517) (2022) YEKED\u00dcZ EMRE, TURAL DEN\u0130Z, ERT\u00dcRK \u0130SMA\u0130L, KARAKAYA SERDAR, EROL C\u0130HAN, ERCELEP \u00d6ZLEM, ARSLAN \u00c7A\u011eATAY, SEVER \u00d6ZLEM NURAY, KILI\u00c7KAP SAADETT\u0130N, \u015eENT\u00dcR<\/li>\n<li><strong>The relationship between systemic immune inflammation index and survival in patients with metastatic renal cell carcinomatreated withtyrosine kinase inhibitors.<\/strong><br>\nScientific Reports, 12(1), 1-9., Doi: 10.1038\/s41598-022-20056-3 (Publication No: 7307182) (2022) B\u0130R Y\u00dcCEL KADR\u0130YE, YEKED\u00dcZ EMRE, KARAKAYA SERDAR, TURAL DEN\u0130Z, ERT\u00dcRK \u0130SMA\u0130L, EROL C\u0130HAN, ERCELEP \u00d6ZLEM, \u015eENT\u00dcRK \u00d6ZTA\u015e N\u0130HAN, ARSLAN \u00c7A\u011eATAY, U\u00c7AR<\/li>\n<li><strong>Efect of Adjuvant Chemotherapy in Stage III Cervical Cancer Patients Treated with Concurrent Chemoradiation: A Multicenter Study<\/strong><br>\nOncology Research and Treatment, 45(5), 254-261., Doi: 10.1159\/000521980 (Publication No: 7571177) (2022) AT\u00c7I MUHAMMED MUSTAFA, AKAG\u00dcND\u00dcZ BARAN, DEM\u0130R MET\u0130N, D\u00d6NMEZ YILMAZ B\u0130NNUR, AKIN TELL\u0130 TU\u011eBA, CAN OR\u00c7UN, \u00c7\u0130L \u0130BRAH\u0130M, G\u00d6KTA\u015e AYDIN SAB\u0130N, \u00d6ZYURT NES<\/li>\n<li><strong>Nivolumab in metastatic renal cell carcinoma: results from the Turkish Oncology Group Kidney Cancer Consortium database.<\/strong><br>\nFuture Oncology, 17(35), 4861-4869., Doi: 10.2217\/fon-2021-0717 (Publication No: 7506054) (2021) YEKED\u00dcZ EMRE, ERT\u00dcRK \u0130SMA\u0130L, TURAL DEN\u0130Z, KARADURMU\u015e NUR\u0130, KARAKAYA SERDAR, HIZAL MUTLU, ARIKAN RUK\u0130YE, ARSLAN \u00c7A\u011eATAY, TABAN HAKAN, K\u00dc\u00c7\u00dcKARDA AHME<\/li>\n<li><strong>Survival and Prognostic Factors in Limited-stage Small-cell Lung Cancer.<\/strong><br>\nJCPSP-Journal of The College of Physicians and Surgeons Pakistan, 31(12), 1433-1437., Doi: 10.29271\/jcpsp.2021.12.1433 (Publication No: 8215561) (2021) ATCI MUHAMMED MUSTAFA, SAK\u0130N ABDULLAH, UYSAL EMRE, AKSARAY FERD\u0130, SELV\u0130 O\u011eUZHAN, CAN OR\u00c7UN<\/li>\n<\/ul>\n<\/div>\n","protected":false},"featured_media":19401,"template":"","categories":[4,28,842],"class_list":["post-19400","idel_doctor","type-idel_doctor","status-publish","has-post-thumbnail","hentry","category-doctors","category-maslak-hospital","category-oncology"],"_links":{"self":[{"href":"https:\/\/acibademinternational.com\/wp-json\/wp\/v2\/idel_doctor\/19400","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/acibademinternational.com\/wp-json\/wp\/v2\/idel_doctor"}],"about":[{"href":"https:\/\/acibademinternational.com\/wp-json\/wp\/v2\/types\/idel_doctor"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/acibademinternational.com\/wp-json\/wp\/v2\/media\/19401"}],"wp:attachment":[{"href":"https:\/\/acibademinternational.com\/wp-json\/wp\/v2\/media?parent=19400"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/acibademinternational.com\/wp-json\/wp\/v2\/categories?post=19400"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}